The largest randomized trial of testosterone therapy found sustained improvements in sexual desire and activity for men with low libido. Here is what the data actually show, and why a comprehensive lab panel comes first.

A September 2026 review asks whether boosting NAD+ protects the aging brain. Here is what human trials actually show, and what a blood NAD+ test cannot tell you.
– Internal links: Longevity Medicine, Peptide Therapy, Functional Medicine

Hot flashes are not always a sign of “too little estrogen.” Unstable dosing, progesterone load, excess androgens, and insulin resistance can keep the brain’s thermostat unstable even when lab estrogen looks high.

New 2026 research links starting hormone therapy in perimenopause or early postmenopause with lower cardiovascular risk. What the study actually showed, and what it did not.